First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 38 101 sessions, April 20, 2026 to September 11, 2026
- Largest daily move
- +56% close of July 9, 2026
Company Description
First Tracks Biotherapeutics (NASDAQ: TRAX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.3B.
TRAX has declined 22.1% over the past month. The last closing price was $36.44.
This page collects what Stock Titan holds for TRAX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
First Tracks Biotherapeutics (TRAX) closed at $36.44 on September 11, 2026. Over the past month, the price has lost 22.1%.
TRAX Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
First Tracks Biotherapeutics has 5 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, conferences. View all TRAX news →
SEC Filings
First Tracks Biotherapeutics has filed 5 recent SEC filings, including 4 Form 4, 1 Form 144. The most recent filing was submitted on September 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRAX SEC filings →
Insider Radar
Insider selling at First Tracks Biotherapeutics over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Upcoming Events
Morgan Stanley Meetings
ANB033 celiac top-line data
ANB033 Cohort 1 Data
ANB033 Cohort 2 Data
ANB033 EoE top-line data
EoE Phase 1b Topline
First Tracks Biotherapeutics has 6 upcoming scheduled events. The next event, "Morgan Stanley Meetings", is scheduled for September 16, 2026 (in 2 days). Investors can track these dates to stay informed about potential catalysts that may affect the TRAX stock price.
Short Interest History
Short interest in First Tracks Biotherapeutics (TRAX) currently stands at 3.9 million shares, down 1.6% from the previous reporting period, representing 11.9% of the float. This moderate level of short interest indicates notable bearish positioning. The 6.8 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for First Tracks Biotherapeutics (TRAX) currently stands at 6.8 days, up 45.8% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The ratio has shown significant volatility over the period, ranging from 4.2 to 10.4 days.
TRAX Company Profile & Sector Positioning
First Tracks Biotherapeutics (TRAX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.